Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-09
4:17 pm
Purchase
13GPhathom Pharmaceuticals, Inc.
PHAT
Carlyle Group Inc.
CG
2,935,106
6.7%
2,935,106increase
(New Position)
View
2023-02-23
4:15 pm
Purchase
13DSpruce Biosciences, Inc.
SPRB
Carlyle Group Inc.
CG
3,734,518
9.2%
1,932,000increase
(+107.18%)
View
2023-02-13
2:49 pm
Sale
13GThe Carlyle Group Inc.
CG
Capital World Investors2,217,000
0.6%
-17,098,259decrease
(-88.52%)
View
2023-02-10
4:16 pm
Purchase
13GHilleVax, Inc.
HLVX
Carlyle Group Inc.
CG
1,838,486
5.5%
1,838,486increase
(New Position)
View
2023-02-10
4:16 pm
Sale
13GZoomInfo Technologies Inc.
ZI
Carlyle Group Inc.
CG
36,662,469
9.1%
-7,579,513decrease
(-17.13%)
View
2023-02-10
4:14 pm
Purchase
13GVaxcyte, Inc.
PCVX
Carlyle Group Inc.
CG
2,070,724
2.6%
2,070,724increase
(New Position)
View
2023-02-10
4:02 pm
Sale
13GThe Carlyle Group Inc.
CG
Rubenstein David M.29,249,644
8.1%
-2,000,000decrease
(-6.40%)
View
2023-02-09
10:54 am
Purchase
13GThe Carlyle Group Inc.
CG
VANGUARD GROUP INC24,952,869
6.86%
2,129,460increase
(+9.33%)
View
2023-02-08
2:29 pm
Purchase
13GThe Carlyle Group Inc.
CG
MORGAN STANLEY
MS
23,412,646
6.4%
5,188,324increase
(+28.47%)
View
2023-01-31
4:15 pm
Purchase
13DJasper Therapeutics, Inc.
JSPR
Carlyle Group Inc.
CG
8,761,891
8%
3,133,333increase
(+55.67%)
View
2023-01-23
5:15 pm
Purchase
13DVertical Capital Income Fund
VCIF
Carlyle Group Inc.
CG
3,718,256
35.8%
3,718,256increase
(New Position)
View
2022-12-20
4:30 pm
Sale
13DSoleno Therapeutics, Inc.
SLNO
Carlyle Group Inc.
CG
0
0%
-18,368,564decrease
(Position Closed)
View
2022-08-29
5:27 pm
Purchase
13GMKS Instruments, Inc.
MKSI
Carlyle Group Inc.
CG
8,482,732
12.8%
8,482,732increase
(New Position)
View
2022-08-11
5:03 pm
Purchase
13DExicure, Inc.
XCUR
Carlyle Group Inc.
CG
285,430
5.7%
285,430increase
(New Position)
View
2022-08-11
5:01 pm
Purchase
13DVera Therapeutics, Inc.
VERA
Carlyle Group Inc.
CG
2,970,156
11.1%
2,970,156increase
(New Position)
View
2022-08-11
5:00 pm
Purchase
13DAdicet Bio, Inc.
ACET
Carlyle Group Inc.
CG
2,152,959
5.4%
2,152,959increase
(New Position)
View
2022-08-11
4:58 pm
Purchase
13DNuCana plc
NCNA
Carlyle Group Inc.
CG
3,353,134
6.4%
3,353,134increase
(New Position)
View
2022-08-11
4:56 pm
Purchase
13DSoleno Therapeutics, Inc.
SLNO
Carlyle Group Inc.
CG
18,368,564
15.3%
18,368,564increase
(New Position)
View
2022-08-11
4:55 pm
Purchase
13DeFFECTOR Therapeutics, Inc.
EFTR
Carlyle Group Inc.
CG
4,829,891
11.7%
4,829,891increase
(New Position)
View
2022-08-11
4:52 pm
Purchase
13DReneo Pharmaceuticals, Inc.
RPHM
Carlyle Group Inc.
CG
2,087,957
8.5%
2,087,957increase
(New Position)
View
Goto 0, 1, 2, 3, Next